Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions

Details for Australian Patent Application No. 2003214938 (hide)

Owner PHARMACIA CORPORATION

Inventors McMahon, Ellen G; Rudolph, Amy E

Agent Spruson & Ferguson

Pub. Number AU-A-2003214938

PCT Number PCT/US03/02723

PCT Pub. Number WO2003/063846

Priority 60/353,801 30.01.02 US

Filing date 30 January 2003

Wipo publication date 2 September 2003

International Classifications

A61K 031/00

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/353,801 30.01.02 US

18 September 2003 Application Open to Public Inspection

  Published as AU-A-2003214938

15 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003214939-TIME TRACKING LOOP FOR DIVERSITY PILOTS

2003214937-Iris fixated intraocular lens suitable for use with attaching instrument